Announcements Trials
Browse Landscape

Phase

Phase 3 3

Status

Terminated 2Completed 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Plasma cell 1Lymphoid 1CNS 1

Conditions

Lymphoma 23Lymphoma, Non-Hodgkin 22Lymphoma, Large B-Cell, Diffuse 16Hodgkin Disease 16Lymphoma, Mantle-Cell 13Lymphoma, Follicular 13Burkitt Lymphoma 9Multiple Myeloma 7Lymphoma, Large-Cell, Immunoblastic 6Lymphoma, B-Cell 6Glioblastoma 6Lymphoma, B-Cell, Marginal Zone 5Leukemia, Lymphocytic, Chronic, B-Cell 5Leukemia 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma, T-Cell 4Gliosarcoma 4Glioma 4Recurrence 3Neoplasms, Plasma Cell 3Neoplasms 3Leukemia, Myeloid, Acute 3Congenital Abnormalities 3Astrocytoma 3Waldenstrom Macroglobulinemia 2Primary Myelofibrosis 2Pdgfra-Associated Chronic Eosinophilic Leukemia 2Myeloproliferative Disorders 2Myelodysplastic-Myeloproliferative Diseases 2Myelodysplastic Syndromes 2

Interventions

Gemcitabine 57Paclitaxel 50Cyclophosphamide 45pembrolizumab 44Carboplatin 41Bevacizumab 38Cisplatin 33Docetaxel 31Fluorouracil 30Nivolumab 29Capecitabine 29Pemetrexed 24Irinotecan 24Oxaliplatin 23Dexamethasone 23Ipilimumab 22Leucovorin 21Radiotherapy 20Sorafenib 19Doxorubicin 19Everolimus 18Cetuximab 18fludarabine 17Albumin-Bound Paclitaxel 17trametinib 15Sunitinib 15Rituximab 15Erlotinib Hydrochloride 15130-nm albumin-bound paclitaxel 15Prednisone 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Has results × Neoplasms × Carmustine × Clear all
NCT02366663 2018-03-12

SPINOZA

City of Hope Medical Center

Phase 3 Terminated
3 enrolled 8 charts
Lymphoid

Immune System Diseases, Immunoproliferative Disorders, Lymphatic Diseases, Lymphoma, Lymphoma, Non-Hodgkin, Lymphoproliferative Disorders, Neoplasms, Neoplasms by Histologic Type, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse

NCT00083551 2015-11-23

UARK 98-026 TT II: Multiple Myeloma Evaluating Anti-Angiogenesis With Thalidomide and Post-Transplant Consolidation Chemotherapy

University of Arkansas

Phase 3 Completed
668 enrolled 7 charts
Plasma cell

Multiple Myeloma, Neoplasms

NCT00761280 2014-11-14

SAPPHIRE

Isarna Therapeutics GmbH

Phase 3 Terminated
27 enrolled 28 charts
CNS

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡